CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
3.790
-0.160 (-4.05%)
Nov 7, 2024, 4:00 PM EST - Market closed

CollPlant Biotechnologies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
4373931757131
Upgrade
Market Cap Growth
-38.74%-21.52%-46.69%147.09%129.10%93.06%
Upgrade
Enterprise Value
3047631326934
Upgrade
Last Close Price
3.956.398.3516.3610.775.70
Upgrade
PE Ratio
--10.31-5.44818.00-12.82-2.55
Upgrade
PS Ratio
65.656.68311.8811.1811.5313.33
Upgrade
PB Ratio
2.182.582.893.8815.817.56
Upgrade
P/FCF Ratio
-16.24-19.69-6.23163.01-14.48-4.30
Upgrade
P/OCF Ratio
-20.70-26.49-6.8169.94-15.90-5.42
Upgrade
EV/Sales Ratio
43.124.32211.868.4611.2514.76
Upgrade
EV/EBITDA Ratio
-2.12-7.38-3.95157.99-13.98-4.82
Upgrade
EV/EBIT Ratio
-2.00-6.30-3.712036.83-12.33-4.48
Upgrade
EV/FCF Ratio
-10.47-12.72-4.23123.39-14.13-4.76
Upgrade
Debt / Equity Ratio
0.160.110.090.080.760.89
Upgrade
Debt / EBITDA Ratio
---2.43--
Upgrade
Debt / FCF Ratio
-0.97-0.85-0.193.36-0.69-0.50
Upgrade
Asset Turnover
0.020.300.010.500.570.24
Upgrade
Inventory Turnover
2.141.860.321.712.792.21
Upgrade
Quick Ratio
6.078.339.7314.601.301.16
Upgrade
Current Ratio
6.278.6210.2014.961.681.46
Upgrade
Return on Equity (ROE)
-61.55%-23.16%-43.73%0.96%-134.83%-234.83%
Upgrade
Return on Assets (ROA)
-33.77%-13.06%-24.01%0.13%-32.41%-48.91%
Upgrade
Return on Capital (ROIC)
-36.23%-14.08%-25.47%0.14%-44.95%-72.43%
Upgrade
Earnings Yield
-40.57%-9.59%-18.15%0.14%-8.16%-36.13%
Upgrade
FCF Yield
-8.14%-5.08%-16.06%0.61%-6.91%-23.28%
Upgrade
Buyback Yield / Dilution
-1.97%-3.23%7.80%-73.76%-38.12%-13.73%
Upgrade
Total Shareholder Return
-1.97%-3.23%7.80%-73.76%-38.12%-13.73%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.